FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE)

CUSIP: 31189P102

Q4 2013 13F Holders as of 31 Dec 2013

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
114,331,829
Total 13F shares
3,929,193
Share change
0
Total reported value
$24,673,622
Price per share
$6.28
Number of holders
15

Quarterly Holders Quick Answers

What is CUSIP 31189P102?
CUSIP 31189P102 identifies FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) as of Q4 2013

As of 31 Dec 2013, FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) was held by 15 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,929,193 shares. The largest 10 holders included WELLINGTON MANAGEMENT CO LLP, KINGDON CAPITAL MANAGEMENT, L.L.C., ORBIMED ADVISORS LLC, FARALLON CAPITAL MANAGEMENT LLC, Board of Trustees of The Leland Stanford Junior University, PRINCIPAL FINANCIAL GROUP INC, GOLDMAN SACHS GROUP INC, MILLENNIUM MANAGEMENT LLC, VANGUARD GROUP INC, and DEUTSCHE BANK AG\. This page lists 15 institutional shareholders reporting positions in this security for the Q4 2013 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.